These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9950212)

  • 1. Mammary tumor formation in p53- and BRCA1-deficient mice.
    Cressman VL; Backlund DC; Hicks EM; Gowen LC; Godfrey V; Koller BH
    Cell Growth Differ; 1999 Jan; 10(1):1-10. PubMed ID: 9950212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of ionizing radiation and genetic background on mammary tumorigenesis in p53-deficient mice.
    Backlund MG; Trasti SL; Backlund DC; Cressman VL; Godfrey V; Koller BH
    Cancer Res; 2001 Sep; 61(17):6577-82. PubMed ID: 11522657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.
    Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T
    Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brca1 heterozygous mice have shortened life span and are prone to ovarian tumorigenesis with haploinsufficiency upon ionizing irradiation.
    Jeng YM; Cai-Ng S; Li A; Furuta S; Chew H; Chen PL; Lee EY; Lee WH
    Oncogene; 2007 Sep; 26(42):6160-6. PubMed ID: 17420720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans.
    Moynahan ME
    Oncogene; 2002 Dec; 21(58):8994-9007. PubMed ID: 12483515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation.
    Deng CX; Scott F
    Oncogene; 2000 Feb; 19(8):1059-64. PubMed ID: 10713690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice.
    Brodie SG; Xu X; Qiao W; Li WM; Cao L; Deng CX
    Oncogene; 2001 Nov; 20(51):7514-23. PubMed ID: 11709723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.
    Xu X; Qiao W; Linke SP; Cao L; Li WM; Furth PA; Harris CC; Deng CX
    Nat Genet; 2001 Jul; 28(3):266-71. PubMed ID: 11431698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.
    Holstege H; Joosse SA; van Oostrom CT; Nederlof PM; de Vries A; Jonkers J
    Cancer Res; 2009 Apr; 69(8):3625-33. PubMed ID: 19336573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA1 carries tumor suppressor activity distinct from that of p53 and p21.
    Randrianarison V; Marot D; Foray N; Cabannes J; Méret V; Connault E; Vitrat N; Opolon P; Perricaudet M; Feunteun J
    Cancer Gene Ther; 2001 Oct; 8(10):759-70. PubMed ID: 11687899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent met oncogene amplification in a Brca1/Trp53 mouse model of mammary tumorigenesis.
    Smolen GA; Muir B; Mohapatra G; Barmettler A; Kim WJ; Rivera MN; Haserlat SM; Okimoto RA; Kwak E; Dahiya S; Garber JE; Bell DW; Sgroi DC; Chin L; Deng CX; Haber DA
    Cancer Res; 2006 Apr; 66(7):3452-5. PubMed ID: 16585167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A targeted disruption of the murine Brca1 gene causes gamma-irradiation hypersensitivity and genetic instability.
    Shen SX; Weaver Z; Xu X; Li C; Weinstein M; Chen L; Guan XY; Ried T; Deng CX
    Oncogene; 1998 Dec; 17(24):3115-24. PubMed ID: 9872327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
    Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
    Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair.
    Hartman AR; Ford JM
    Nat Genet; 2002 Sep; 32(1):180-4. PubMed ID: 12195423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The p53 mutational spectrum associated with BRCA1 mutant ovarian cancer.
    Buller RE; Lallas TA; Shahin MS; Sood AK; Hatterman-Zogg M; Anderson B; Sorosky JI; Kirby PA
    Clin Cancer Res; 2001 Apr; 7(4):831-8. PubMed ID: 11309330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development.
    Jerry DJ; Kittrell FS; Kuperwasser C; Laucirica R; Dickinson ES; Bonilla PJ; Butel JS; Medina D
    Oncogene; 2000 Feb; 19(8):1052-8. PubMed ID: 10713689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense inhibition of BRCA1 expression and molecular analysis of hereditary tumors indicate that functional inactivation of the p53 DNA damage response pathway is required for BRCA-associated tumorigenesis.
    Reedy MB; Hang T; Gallion H; Arnold S; Smith SA
    Gynecol Oncol; 2001 Jun; 81(3):441-6. PubMed ID: 11371136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation.
    Xu X; Wagner KU; Larson D; Weaver Z; Li C; Ried T; Hennighausen L; Wynshaw-Boris A; Deng CX
    Nat Genet; 1999 May; 22(1):37-43. PubMed ID: 10319859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain.
    Blackburn AC; McLary SC; Naeem R; Luszcz J; Stockton DW; Donehower LA; Mohammed M; Mailhes JB; Soferr T; Naber SP; Otis CN; Jerry DJ
    Cancer Res; 2004 Aug; 64(15):5140-7. PubMed ID: 15289317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1 shifts p53-mediated cellular outcomes towards irreversible growth arrest.
    Ongusaha PP; Ouchi T; Kim KT; Nytko E; Kwak JC; Duda RB; Deng CX; Lee SW
    Oncogene; 2003 Jun; 22(24):3749-58. PubMed ID: 12802282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.